Oscar Health Statistics
Share Statistics
Oscar Health has 211.75M shares outstanding. The number of shares has increased by 8.16% in one year.
| Shares Outstanding | 211.75M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 2.32% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 174.34M |
| Failed to Deliver (FTD) Shares | 50.64K |
| FTD / Avg. Volume | 1.25% |
Short Selling Information
The latest short interest is 12.41M, so 5.86% of the outstanding shares have been sold short.
| Short Interest | 12.41M |
| Short % of Shares Out | 5.86% |
| Short % of Float | 7.13% |
| Short Ratio (days to cover) | 4.36 |
Valuation Ratios
The PE ratio is -7.49 and the forward PE ratio is 24.21.
| PE Ratio | -7.49 |
| Forward PE | 24.21 |
| PS Ratio | 0.35 |
| Forward PS | 0.3 |
| PB Ratio | 2.52 |
| P/FCF Ratio | -6.81 |
| PEG Ratio | n/a |
Enterprise Valuation
Oscar Health Inc. has an Enterprise Value (EV) of 456.61M.
| EV / Earnings | -1.69 |
| EV / Sales | 0.08 |
| EV / EBITDA | -2.15 |
| EV / EBIT | -1.94 |
| EV / FCF | -1.53 |
Financial Position
The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.37.
| Current Ratio | 1.26 |
| Quick Ratio | 1.26 |
| Debt / Equity | 0.37 |
| Total Debt / Capitalization | 27.09 |
| Cash Flow / Debt | -0.91 |
| Interest Coverage | -9.58 |
Financial Efficiency
Return on equity (ROE) is -0.34% and return on capital (ROIC) is -21.59%.
| Return on Equity (ROE) | -0.34% |
| Return on Assets (ROA) | -0.08% |
| Return on Capital (ROIC) | -21.59% |
| Revenue Per Employee | 2.44M |
| Profits Per Employee | -112.80K |
| Employee Count | 2.40K |
| Asset Turnover | 1.63 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 3.29M |
| Effective Tax Rate | -0.01 |
Stock Price Statistics
The stock price has increased by 75.16% in the last 52 weeks. The beta is 1.66, so Oscar Health 's price volatility has been higher than the market average.
| Beta | 1.66 |
| 52-Week Price Change | 75.16% |
| 50-Day Moving Average | 16.51 |
| 200-Day Moving Average | 17.4 |
| Relative Strength Index (RSI) | 38.2 |
| Average Volume (20 Days) | 4.05M |
Income Statement
In the last 12 months, Oscar Health had revenue of $5.86B and earned -$270.73M in profits. Earnings per share was $-1.22.
| Revenue | 5.86B |
| Gross Profit | 5.86B |
| Operating Income | -235.62M |
| Net Income | -270.73M |
| EBITDA | -212.00M |
| EBIT | -235.62M |
| Earnings Per Share (EPS) | -1.22 |
Balance Sheet
The company has $1.87B in cash and $298.78M in debt, giving a net cash position of $1.57B.
| Cash & Cash Equivalents | 1.87B |
| Total Debt | 298.78M |
| Net Cash | 1.57B |
| Retained Earnings | -2.88B |
| Total Assets | 4.48B |
| Working Capital | -3.08B |
Cash Flow
In the last 12 months, operating cash flow was -$272.16M and capital expenditures -$25.58M, giving a free cash flow of -$297.74M.
| Operating Cash Flow | -272.16M |
| Capital Expenditures | -25.58M |
| Free Cash Flow | -297.74M |
| FCF Per Share | -1.34 |
Margins
Gross margin is 100%, with operating and profit margins of -4.02% and -4.62%.
| Gross Margin | 100% |
| Operating Margin | -4.02% |
| Pretax Margin | -4.56% |
| Profit Margin | -4.62% |
| EBITDA Margin | -3.62% |
| EBIT Margin | -4.02% |
| FCF Margin | -5.08% |
Dividends & Yields
OSCR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -8.92% |
| FCF Yield | -10.28% |
Analyst Forecast
The average price target for OSCR is $22, which is 60.8% higher than the current price. The consensus rating is "Buy".
| Price Target | $22 |
| Price Target Difference | 60.8% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
Scores
| Altman Z-Score | 0.73 |
| Piotroski F-Score | 5 |